Veterinary Medicine International

Veterinary Medicine International / 2011 / Article

Research Article | Open Access

Volume 2011 |Article ID 140293 |

J. Wabo Poné, Olivia Fossi Tankoua, Jeannette Yondo, Marie Claire Komtangi, Mpoame Mbida, C. F. Bilong Bilong, "The In Vitro Effects of Aqueous and Ethanolic Extracts of the Leaves of Ageratum conyzoides (Asteraceae) on Three Life Cycle Stages of the Parasitic Nematode Heligmosomoides bakeri (Nematoda: Heligmosomatidae)", Veterinary Medicine International, vol. 2011, Article ID 140293, 5 pages, 2011.

The In Vitro Effects of Aqueous and Ethanolic Extracts of the Leaves of Ageratum conyzoides (Asteraceae) on Three Life Cycle Stages of the Parasitic Nematode Heligmosomoides bakeri (Nematoda: Heligmosomatidae)

Academic Editor: David W. Horohov
Received18 Dec 2010
Revised27 Mar 2011
Accepted16 May 2011
Published28 Jun 2011


A comparative in vitro study was carried out to determine the ovicidal and larvicidal activity of aqueous and ethanolic extracts of Ageratum conyzoides (Asteraceae) leaves on the eggs (unembryonated and embryonated), first and second larval stages of Heligmosomoides bakeri. Four different concentrations (0.625, 1.25, 2.5, and 3.75 mg·mL−1) of both aqueous and ethanolic extracts were tested. Distilled water and 5% tween were used as negative controls in the bioassay. In fact, they did not affect development of eggs, hatching, and larval survival. The extract activities were dose dependent. The ethanolic extract was more potent against embryonation (39.6 ± 2.9%) than the aqueous extract (53.3 ± 10.9%) at the highest concentration (3.75 mg·ml−1). Both types of extracts killed larvae. Mebendazole proved more lethal (EC50 of 0.745 and 0.323 mg·mL−1, resp., for L1 and L2 larvae). The aqueous extracts were the least lethal (EC50 of 4.76 and 2.29 mg·mL−1, resp., for L1 and L2 larvae). The ethanolic extracts showed intermediate activity (EC50 of 1.323 and 1.511 mg·mL−1, resp., for L1 and L2 larvae). It is concluded that the ovicidal and larvicidal properties of aqueous and ethanolic extracts of Ageratum conyzoides leaves are demonstrated in this work.

1. Introduction

Helminthiases are worldwide and constitute a major health issue. More than 1 billion people are infected with gastro-intestinal helminths. Helminthiases are more common in the tropics where poor hygienic conditions and poverty increase the risk of infection. In addition, these diseases are responsible for mortality in human beings and affect especially children of school age, thus, compromising their growth, intellectual, development and their school performance as well as increasing their vulnerability to other infections. On the other hand, in domesticated animals, helminth infections impair health, welfare, and productivity. Worm infections result in increased death rate and poor growth and reproduction. To control verminosis, patients and likewise farmers use synthetic anthelmintic drugs. Unfortunately, these substances are not only less available in the countries of the South but also their cost in local markets is relatively high. Moreover, for more than two decades now, new anthelmintic molecules have not been discovered. Also, the misuse of these drugs for many years had led to the development of resistant worm strains. Some side effects are noted and the use of disinfectants to control free stage of parasites is harmful to the environment [1]. This has motivated investigation into alternative approaches. Phytotherapy based on the use of preparation of medicinal plant, with low cost and efficiency, remains the most serious alternative to modern anthelmintics drugs. The discovery of new natural, less expensive, and nontoxic products remains a continued quest in the control of helminths worldwide [2, 3]. Studies carried out in that direction include those of Alawa et al. [4], Wabo Poné et al. [57], Maciel et al. [8], and M.-M. Claire et al. [9] who assessed the in vitro anthelmintic activities of extracts of: Vernonia amygdalina and Annona senegalensis in Nigeria, Canthium mannii in Cameroon, Melia azedarach in Brazil, and Cucurbita moschata in Guadeloupe, respectively. In Cameroon, Ageratum conyzoides commonly called “king of herbs” is used to treat different human ailments and as worm medicine in some countries. In the present study, a comparative assay was performed to evaluate the ovicidal and larvicidal properties of aqueous and ethanolic extracts of the leaves of Ageratum conyzoides against Heligmosomoides bakeri, a gastrointestinal nematode parasite of rodents.

2. Materials and Methods

The A. conyzoides leaves used in this study were harvested in Dschang, Menoua division, West Region of Cameroon. They were then dried in an oven at 50°C for 7 days, ground, and stored in airtight plastic bags in the laboratory for further use.

2.1. Preparation of Extracts

Two types of extracts (aqueous and ethanolic) were prepared to compare their activities.

Ethanolic Extract
The procedure used is as described by Wabo Poné et al. [5, 6]. Briefly, 445 grams of stored powder were macerated in 4 liters of ethanolic 95%. The mixture was stirred daily and 72 hours later filtered through a filter paper of pore size 2.5 μm. The ethanolic extract was obtained using the procedure described by Ciulei [10]. This was followed by the dilution of 100 mg of the extract (concentrated using a rotary evaporator) with 1 ml of 5% tween which helped dilute the extract and to facilitate the mixing with water. After 5–10 min, distilled water was added to obtain a total volume of 10 mL which produced a stock solution of 10 mg·mL−1 from which a series of dilutions were made to obtain solutions of 1.250, 2.5, 5.0, and 7.5 mg·mL−1 concentrations. The final tested concentrations were 0.625, 1. 25, 2.5, and 3.75 mg·mL−1

Aqueous Extract
The above procedure was used for the aqueous extract except that distilled water was used and the maceration took 48 hours (to avoid fungal growth). Also, the solvent was dried for 24 hours in an oven heated to 50°C.

2.2. Reference Drug

The reference drug, Mebendazole (MBZ), was used only for the larvicidal tests. The drug was bought in a local pharmacy and diluted with distilled water (DW) to obtain a stock solution with the same concentration as with organic extracts. The negative controls used for the bioassay were 5% tween and DW.

2.3. Recovery of Nematode Eggs

Heligmosomoides bakeri (previously known as Nematospiroides dubius and H. polygyrus; see [11, 12]) fresh eggs were obtained from the faeces of experimentally infected mice according to Michael et al. [13]. Briefly, 3 g of faeces were collected, homogenised in a mortar, suspended in saturated salt solution (0.4% NaCl), and cleaned of organic debris by filtration through sieves (1 mm and 150 μm) into a 100 mL beaker. The contents of the later were poured into four tubes and centrifuged at 1000 g for 5 min. The supernatant containing eggs was poured through a 45 μm mesh sieve. The material retained on the sieve and containing eggs was washed with tap water to remove the salt solution. The sieve was then turned over, the opposite side was washed with tap water and eggs were thus collected in a Petri dish (=16 cm) [14].

2.4. Evaluation of Ovicidal Activity

The ovicidal efficacy test of the different extracts was performed using two different procedures. To assess the effects of the extracts on fresh eggs, 1mL of suspension containing 30 parasite eggs was distributed in each of 12 Petri dishes (35 mm ×10 mm) and mixed with the same volume of a specific concentration of a given extract. The Petri dishes were covered and the eggs incubated at room temperature for 24 hours, after which 2 to 3 drops of Lugol’s iodine were added in each Petri dish to fix the different life cycle stages and the number of embryonated eggs per Petri dish was counted under a microscope (at 4x magnification). The percentage of embryonation (EM%) was determined as follows [5]:EM(%)=NumberofembryonatedeggsNumberofeggsinculture×100.(1)

To assess the effects of the extracts on the hatching mechanism, the same number of unembryonated eggs, distributed in Petri dishes as above, was allowed at room temperature for about 24 hours until the eggs had developed to the fully embryonated prehatch stage. When the first stage larvae became transparent and were actively moving within the egg envelope (>90% in the control Petri dish), 1 ml of a range of each concentration of extract was added to Petri dishes. The Petri dishes were then covered and incubated for a further 6 hours at room temperature (24°C) to allow hatching to be completed in the control dish. Thereafter, 2 to 3 drops of Lugol’s iodine were added to each Petri dish to fix the different life cycle stages and all embryonated eggs. The first-stage larvae (L1) were counted under a microscope (at 4x magnification). The hatching rate (HR%) was computed as follows [6]: HR(%)=NumberofL1larvaeNumberofembryonatedeggsinculture×100.(2)

2.5. Recovery of Nematode Larvae

Eggs were cultured using the technique described by Smyth [15]. Briefly, 3 ml of the egg suspension was poured on filter paper at the bottoms of two Petri dishes, which were then covered to maintain a high relative humidity (65–67%) to prevent the dishes from drying out, and was stored at 24°C. After 3 and 4-5 days of incubation, L1 and L2 larvae, respectively, were observable in Petri dishes and were concentrated with a Baermann apparatus [15, 16].

2.6. Evaluation of Larvicidal Activity

To assess the effects of the extracts on L1 and L2 larvae, 1 mL of a solution containing about 30–40 parasite larvae was distributed in each of 12 Petri dishes (35 mm ×10 mm) and mixed with the same volume of a specific concentration of each extract. The dishes were covered and the larvae incubated at room temperature for 24 hours, after which the number of dead or immobilised larvae was counted under a microscope (at 4x magnification). The percent mortality (Mc%) was determined using Abbott’s formula for corrected mortality [7]: Mc(%)=MceMt100Mt×100,(3) where Mce is the mortality obtained during the test and Mt the mortality registered in the negative control dishes. It is considered that when the mortality rate in the leter dishes is less than 5%, Mc = Mce [17].

2.7. Data Analysis

At equal concentration, the mean embryonation rates, hatching rates, and larval mortality rates due to the two types of extracts were compared using the chi-square at the 𝑃<0.05 significance level. The 50 per cent effective concentration (EC50) was determined using the regression lines of the probit according to the decimal logarithm of the concentration. All tests were repeated four times for each treatment and control.

3. Results

The variation of mean embryonation rate of H. bakeri eggs according to the concentration of extracts of A. conyzoides leaves is shown in Table 1. Overall, the effect was dose dependent. At a concentration of 2.5 mg·mL−l, the mean embryonation rates were 75.7 ± 5.7% and 77.7 ± 13.3% for aqueous and ethanolic extract, respectively. At 3.75 mg.mL−1, the embryonation rates were moderate and similar in solution containing both extracts. The mean embryonation rate was maximum (100 ± 0.0%) in distilled water and 5% tween.

TreatmentNegative controlsTested concentrations (mg â‹… mL−1)
Distilled water5% tween0.6251.252.53.75

EmbryonationAqueous extract100.0 ± 0.0NA94.5 ± 7.885.1 ± 6.275.7 ± 5.753.3 ± 10.9
Ethanolic extractNA100.0 ± 0.096.1 ± 2.991.5 ± 6.077.7 ± 13.339.6 ± 2.9

hatchingAqueous extract97.9 ± 2.6NA97.0 ± 6.185.2 ± 13.859.1 ± 26.248.7 ± 27.2
Ethanolic extractNA100.0 ± 0.061.4 ± 8.447.5 ± 9.626.4 ± 12.526.7 ± 7.3

NA: not applicable.

The variation of the mean hatching rate of L1 larvae of H. bakeri according to the concentration of extract is illustrated in Table 1. The aqueous extracts did not affect egg hatching. At a concentration of 3.75 mg·mL−1, mean hatching rate was 48.7 ± 27.2%. The negative controls did not affect the hatching rate (97.9 ± 2.6 and 100% hatching rate for 5% tween and DW, resp.).

The effects of different extracts and Mebendazole (MBZ) on L1 larvae of H. bakeri after 24 h of contact are shown in Table 2. Larval mortality rate was highest at 2.5 and 3.75 mg.mL−1. The mean mortality rate due to ethanolic extract was 96.3 ± 4.8 and 99.4 ± 1.2% and MBZ (89.4 ± 7.4 and 84.35 ± 3.83%) was similar (𝑃>0.05) and higher (𝑃<0.05) than that attributed to aqueous extract (32.3 ± 12.4 and 55.0 ± 22.3%) with the same concentrations. Distilled water and 5% tween did not affect the survival of the larvae with mortality rate of 3.5 ± 5.0% and 3.0 ± 4.8%, respectively. The EC50 obtained were 2.14 mgmL−1, 066 mg.mL−1, and 0.37 mg.mL−1 for aqueous, ethanolic extracts, and mebendazole respectively. Twenty-four (24) hours after incubation of L2 larvae in three treatments, the larval mortality increases with that of the concentrations (Table 2). With the three first concentration, the mortality due to MBZ (77.0 ± 3.5%, 86.7 ± 5.2%, 96.0 ± 0.8%) was higher (𝑃>0.05) than that due to aqueous extract (32.6 ± 20.3%, 40.8 ± 15.0%, 50.1 ± 13.1%) and to ethanolic extract (13.6 ± 7.0%, 32.5 ± 4.2%, 35.4 ± 29.0%). With the highest concentration, the mortalities were similar (𝑃>0.05) and higher (𝑃<0.05) in ethanolic extract (95.48 ± 5.2%) and MBZ (100 ± 0.0%) than in aqueous extract (58.2 ± 20.0%). Distilled water and 5% tween did not affect H. bakeri larval survival with a mortality rate of 3.5 ± 5.0% and 3.0 ± 4.8% for DW and 5% tween, respectively. Regression analysis indicates that there was a dose-dependent relationship and the EC50 obtained were 2.29 mg·mL−1, 1.51 mg·mL−1, and 0.32 mg·ml−1 for aqueous, ethanolic extracts, and mebendazole, respectively.

Larval stagesTreatmentNegative controlsTested concentrations (mg·mL−1)
Distilled water5% tween0.6251.252.53.75

L1 larvaeAqueous extract3.5 ± 5.0NA6.0 ± 5.18.1 ± 1.032.3 ± 12.455.0 ± 22.3
Ethanolic extractNA3.0 ± 4.86.7 ± 4.560.7 ± 6.896.3 ± 4.899.4 ± 1.2
Mebendazole3.5 ± 5.0NA33.8 ± 21.132.2 ± 12.489.4 ± 7.484.4 ± 3.8

L2 larvaeAqueous extract3.5 ± 5.0NA32.6 ± 20.3440.8 ± 15.050.1 ± 13.158.2 ± 20.0
Ethanolic extractNA3.0 ± 4.813.6 ± 7.032.5 ± 4.235.4 ± 29.095.5 ± 5.2
Mebendazole3.5 ± 5.0NA77.0 ± 3.586.7 ± 5.296.0 ± 0.8100.0 ± 0.0

NA: not applicable.

4. Discussion

Generally, the extracts of A. conyzoides affect embryonic development and hatching rate of H. bakeri. Similar findings were shown by Wabo Poné et al [5] with the extracts of Canthium mannii. The ovicidal activities of the extracts of A. conyzoides could be due to the fact that the active compounds penetrated the egg shell and stopped the segmentation of blastomeres or paralysed the larvae inside embryonated egg. The fact that aqueous solution seems to be more efficient against embryonation of eggs than ethanolic could be due to the composition of each extract. In fact, Ciulei [10] stated that aqueous extract contained hydro-soluble compounds compared to ethanolic extract which possesses, in addition to hydrosoluble substances, lipid substances, alkaloids, and polyphenols. However, since the layers of the egg shell are hydrophobic, the aqueous extract has the ability to penetrate the layers than the ethanolic extract which has an oil aspect in this work. Extracts of A. conyzoides likewise showed larvicidal activity, and L1 larvae were more sensible to extract than the L2 confirming the literature findings [18]. The higher larvicidal activity of ethanolic extract could be due to secondary metabolites such as tannins, flavonoids, polyphenol, coumarins, or alkaloids isolated in this medicinal plant [19]. These compounds may create unfavorable conditions to the survival of the larvae.

5. Conclusion

From the above results, it is concluded that aqueous and ethanolic extracts of A. conyzoides have potent anthelmintic activity. Further experiment incorporating in vivo model studies are required to find out and to establish effectiveness and pharmacological rationale for the use of A. conyzoides extracts as anthelmintic drug. Further studies to isolate active constituent from extracts to establish mechanism of action are required. In addition, toxicological studies should be carried out.


  1. A. R. Dunn and C. Greiner, Managing Hookworms in the Lanscape, Institut of Food and Agricultural Science (IFAS), University of Florida, 1997.
  2. U. Y. Cirak, E. Crulegen, and C. Baner, “Benzimidazole resistance in Cyathosmin populations on horse farm in western Anatobia, Turkey,” Parasitology Research, vol. 93, no. 5, pp. 392–395, 2004. View at: Google Scholar
  3. A. J. Wolstenholme, I. Fairweather, R. Prichard, G. Von Samson-Himmelstjerna, and N. C. Sangster, “Drug resistance in veterinary helminths,” Trends in Parasitology, vol. 20, no. 10, pp. 469–476, 2004. View at: Publisher Site | Google Scholar
  4. C. B. F. Alawa, A. M. Adamu, J. O. Gefu et al., “In vitro screening of two Nigerian medicinal plants (Vernonia amygdalina and Annona senegalensis) for anthelmintic activity,” Veterinary Parasitology, vol. 113, no. 1, pp. 73–81, 2003. View at: Publisher Site | Google Scholar
  5. J. Wabo Poné, C. F. Bilong Bilong, and M. Mpoame, “In vitro nematicidal activity of extracts of Canthium mannii (Rubiaceae), on different life-cycle stages of Heligmosomoides polygyrus (Nematoda, Heligmosomatidae),” Journal of Helminthology, vol. 84, no. 2, pp. 156–165, 2010. View at: Publisher Site | Google Scholar
  6. J. Wabo Poné, C. F. Bilong Bilong, M. Mpoame, C. F. Ngwa, and C. G. Coles, “In vitro activity of ethanolic, cold and hot water extracts of the stem bark of Canthium mannii (Rubiaceae) on Ancylostoma caninum eggs,” East and Central African Journal of Pharmaceutical Sciences, vol. 9, no. 1, pp. 14–18, 2006. View at: Google Scholar
  7. J. Wabo Poné, M. Mpoame, C. F. Bilong Bilong, and D. Kerboeuf, “Etude comparée in vitro de l'activité nématodicide de l'extrait éthanolique de la poudre d'écorce de Canthium mannii (Rubiaceae) et du Mébendazole,” Revue de Médécine Vétérinaire, vol. 156, no. 12, pp. 633–636, 2005. View at: Google Scholar
  8. M. V. Maciel, S. M. Morais, C. M. Bevilaqua, A. L. Camurça-Vasconcelos, C. T. Costa, and C. M. Castro, “Ovicidal and larvicidal activity of Melia azedarach extracts on Haemonchus contortus,” Veterinary Parasitology, vol. 140, no. 1-2, pp. 98–104, 2006. View at: Publisher Site | Google Scholar
  9. M.-M. Claire, H. Hoste, M. Mathieu, H. Varo, and H. Archimede, “In vitro effects of Cucurbita moshata seed extracts on Haemonchus contortus,” Veterinary Parasitology, vol. 161, no. 1, pp. 99–105, 2009. View at: Publisher Site | Google Scholar
  10. I. Ciulei, Methodology for Analysis of Vegetable Drugs. Practical Manual on the Industrial Utilisation of Medicinal and Aromatic Plants, Bucharest Office of UNIDO, Bucharest, Romania, 1982.
  11. J. Cable, P. D. Harris, J. W. Lewis, and J. M. Behnke, “Molecular evidence that Heligmosomoides polygyrus from laboratory mice and wood mice are separate species,” Parasitology, vol. 133, no. 1, pp. 111–122, 2006. View at: Publisher Site | Google Scholar
  12. J. M. Behnke and P. D. Harris, “Heligmosomoides bakeri: a new name for an old worm?” Trends in Parasitology, vol. 26, no. 11, pp. 524–529, 2010. View at: Publisher Site | Google Scholar
  13. B. Michael, P. T. Meinke, and W. Shoop, “Comparison of ivermectin, doramectin, selamectin, and eleven intermediates in a nematode larval development assay,” Journal of Parasitology, vol. 87, no. 3, pp. 692–696, 2001. View at: Google Scholar
  14. J. Euzeby, Diagnostic Expérimental des Helminthoses Animales (Animaux Domestiques, Animaux de Laboratoire, Primate), Informations Techniques des Services Vétérinaires, Paris, France, 1981, Travaux pratiques d'helminthologie vétérinaire. Livre 1 généralités. Diagnostic ante mortem.
  15. J. D. Smyth, Animal Parasitology, Cambridge University Press, London, UK, 1996.
  16. M. Cheesbrough, Medical Laboratory Manual for Tropical Countries, Cambridge University Press, Cambridge, UK, 2nd edition, 1987.
  17. J. R. Busvine, Méthodes Recommandées Pour la Mesure de la Resistance des Ravageurs aux Pesticides, Organisation des Nations Unies pour l'Alimentation et l'Agriculture, Rome, Italy, 1981.
  18. E. J. L. Soulsby, Helminths, Arthropods and Protozoa of Domesticated Animals, Bailler. Tindall, London, UK, 7th edition, 1982.
  19. L. Okunade Adewole, “Ageratum conyzoides L. (Asteraceae),” Fitoterapia, vol. 73, no. 1, pp. 1–16, 2002. View at: Publisher Site | Google Scholar

Copyright © 2011 J. Wabo Poné et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.